Cancer Escape Map
Organize evidence around the mechanisms that let a cancer persist, evade therapy, recur, or spread — and the evidence required to show those escape routes are closed.
Global Cancer Escape Map
What is still allowing cancer to survive?
CancerDiscoveries tracks not only what appears to work, but the unresolved biological and evidence barriers that can permit persistence, resistance, recurrence, or spread. The goal is to make the remaining cure gap visible and testable.
This is research synthesis, not medical advice. No hypothesis on this page should be used to choose or change treatment.
The cure-gap intelligence model
Opposite Outcomes
Contrast durable responders with nonresponders or rapid progressors in comparable settings and ask which measured differences may explain the divergent outcomes.
Cure Barrier Map
For each cancer type, identify the major unresolved barriers between present treatment evidence and durable disease eradication, while clearly showing uncertainty.
Cure Architecture
Build versioned, falsifiable research hypotheses about which mechanisms may need to be controlled together or in sequence. Hypotheses remain distinct from proven care.
Missing World Map
Show where evidence comes from and where important populations, countries, age groups, or disease contexts remain underrepresented rather than assuming evidence is globally complete.
Breakthrough Reality Check
Translate headline claims into evidence questions: human data, randomization, survival, durability, recurrence, replication, sample size, resistance, safety, and remaining unknowns.
Every conclusion carries an evidence status
- PROVEN — supported by strong clinical or regulatory evidence for the specific claim being made.
- PROMISING — meaningful human evidence exists, but important uncertainty or validation gaps remain.
- HYPOTHESIS — biologically plausible and testable, but not established as effective treatment.
- FAILED / CONTRADICTED — negative or conflicting evidence is preserved because failure teaches us about the remaining barrier.
- UNKNOWN — evidence is missing, too weak, too indirect, or not representative enough to support a conclusion.
How a cure-pathway thesis evolves
- Collect worldwide primary evidence, including negative and contradictory results.
- Identify the cancer-specific mechanisms associated with persistence, resistance, recurrence, metastasis, toxicity limits, or nonresponse.
- Compare opposite outcomes and identify candidate explanatory differences without claiming causation prematurely.
- Map which barriers current approaches address, which remain open, and where evidence is geographically or demographically thin.
- Publish a falsifiable research hypothesis only when its supporting and contradicting evidence is visible.
- Version the hypothesis as new trials, failures, safety findings, replications, and mechanistic discoveries arrive.
Nothing is silently overwritten. Earlier thesis versions should remain auditable so readers can see exactly why the reasoning changed.
Living Cancer Cure Barrier Registry
Each published barrier below is disease-level research synthesis linked to Verified CancerDiscoveries evidence. A HYPOTHESIS label remains a hypothesis even when the record itself has passed editorial review.
No cancer-specific barrier records have passed the Cure Gap verification gate yet. The framework is live, but the registry will remain empty rather than publish unsupported conclusions.
A hard boundary: hypothesis is not treatment
CancerDiscoveries must never convert a mechanistic hypothesis, preclinical result, subgroup signal, or early trial into a claim that a person should take a drug or combination. High-impact medical conclusions remain fail-closed and require the existing editorial evidence gate.
The purpose of the Cure Gap is to expose what humanity still needs to learn and which research questions could most efficiently reduce that uncertainty.